Albumin–globulin ratio is a predictive biomarker of antitumour effect of immune checkpoint inhibitors in cancer patients

Albumin–globulin ratio is a predictive biomarker of antitumour effect of immune checkpoint inhibitors in cancer patients

<p>Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, yet the heterogeneity of treatment responses underscores the need for reliable prognostic biomarkers. The albumin-to-globulin ratio (AGR), an indicator of systemic inflammation and nutritional status, has emerged as a pote...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autore principale:	Kaixiang He (13263834) (author)
Altri autori:	Fujiang Xu (5506013) (author), Li Xiang (586649) (author), Yuhao Luo (2826512) (author)
Pubblicazione:	2025
Soggetti:	Medicine Cell Biology Pharmacology Immunology Cancer Science Policy Mathematical Sciences not elsewhere classified Immune checkpoint inhibitors renal cell carcinoma cancer prognosis therapeutic response
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Table 2_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
di: Rui Wang (52434)
Pubblicazione: (2025)

Table 3_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
di: Rui Wang (52434)
Pubblicazione: (2025)

Table 1_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.xlsx
di: Rui Wang (52434)
Pubblicazione: (2025)

Comparative transcriptome atlas as an assistive modality for complex classification of rare kidney cancers
di: Hasashi Hasumi (21471185)
Pubblicazione: (2025)

Table 1_Mechanistic study of TFE3 breakage in TFE3-rearranged renal cell carcinoma: the perspective of non-canonical DNA structures and their stability.docx
di: Xiaopo Zhang (402895)
Pubblicazione: (2025)

Supplementary Tables TS1-23 from An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas
di: Xiaofan Lu (15049989)
Pubblicazione: (2025)

Data Sheet 3_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
di: Hailong Pang (12841991)
Pubblicazione: (2025)

Data Sheet 2_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
di: Hailong Pang (12841991)
Pubblicazione: (2025)

Data Sheet 1_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
di: Hailong Pang (12841991)
Pubblicazione: (2025)

Additional file 14 of Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma
di: Xu Han (141301)
Pubblicazione: (2025)

Additional file 13 of Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma
di: Xu Han (141301)
Pubblicazione: (2025)

Additional file 12 of Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma
di: Xu Han (141301)
Pubblicazione: (2025)

Additional file 11 of Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma
di: Xu Han (141301)
Pubblicazione: (2025)

Table 1_Machine learning-based differentiation of lung squamous cell carcinoma and adenocarcinoma using clinical-semantic and radiomic features.docx
di: Yanju Li (9697993)
Pubblicazione: (2025)

Table 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.docx
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Table 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Table 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 9_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 10_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 11_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 7_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 8_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 5_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 6_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 4_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Table 1_The CD300c antibody CL7 suppresses tumor growth by regulating the tumor microenvironment in non-small cell lung carcinoma.docx
di: Soyoung Kim (117362)
Pubblicazione: (2025)

Image 3_Pan-cancer multi-omics characterization of calcyphosine and its revealed links to the immune microenvironment and regulatory networks in endometrial carcinoma.jpeg
di: Xi Chen (35903)
Pubblicazione: (2025)

Table 2_Pan-cancer multi-omics characterization of calcyphosine and its revealed links to the immune microenvironment and regulatory networks in endometrial carcinoma.docx
di: Xi Chen (35903)
Pubblicazione: (2025)

Table 1_Pan-cancer multi-omics characterization of calcyphosine and its revealed links to the immune microenvironment and regulatory networks in endometrial carcinoma.xlsx
di: Xi Chen (35903)
Pubblicazione: (2025)

Image 1_Pan-cancer multi-omics characterization of calcyphosine and its revealed links to the immune microenvironment and regulatory networks in endometrial carcinoma.jpeg
di: Xi Chen (35903)
Pubblicazione: (2025)

Image 2_Pan-cancer multi-omics characterization of calcyphosine and its revealed links to the immune microenvironment and regulatory networks in endometrial carcinoma.png
di: Xi Chen (35903)
Pubblicazione: (2025)

Image 4_Pan-cancer multi-omics characterization of calcyphosine and its revealed links to the immune microenvironment and regulatory networks in endometrial carcinoma.png
di: Xi Chen (35903)
Pubblicazione: (2025)

Data Sheet 1_Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study.docx
di: Liying Ren (11143129)
Pubblicazione: (2025)

Supplementary Tables S1-S10 from <i>ACTA2</i> Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer
di: Sunho Park (15053897)
Pubblicazione: (2025)

Table 1_Preoperative TACE with PD-1 inhibitors and TKIs in beyond “up-to-seven” hepatocellular carcinoma: a propensity score matched analysis.docx
di: Deyuan Zhong (13217892)
Pubblicazione: (2025)

Table 1_Low-dose statins combined with repetitive transcranial magnetic stimulation reduce post-stroke depression.docx
di: Chaohua Cui (1793155)
Pubblicazione: (2025)

Table 1_Association between the age-to-serum albumin ratio and all-cause mortality in patients with acute myocardial infarction: a retrospective cohort study.pdf
di: Xue-Cheng Song (22679321)
Pubblicazione: (2025)

Cannot write session to /tmp/vufind_sessions/sess_4hg70cgh4hhebu7uresgmla7rd